Ferran Astorga Jeannette
Known title: Executive Vice PresidentCIK: 0001900614
Associated companies
Transaction History
| ZTS | ▲ Buy | Option Exercise | 431 | — | 2/19/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 190 | $24K | 2/19/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 218 | — | 2/8/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 97 | $12K | 2/8/2026 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 92 | $12K | 2/6/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 206 | — | 2/6/2026 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 214 | — | 2/8/2025 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 86 | $15K | 2/8/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 477 | — | 2/8/2025 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 191 | $33K | 2/8/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 203 | — | 2/6/2025 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 82 | $14K | 2/6/2025 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 221 | — | 2/10/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 78 | $15K | 2/10/2024 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 334 | — | 2/10/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 133 | $26K | 2/10/2024 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 212 | — | 2/8/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 85 | $17K | 2/8/2024 | View on chart |
| ZTS | ▼ Sell | Tax Withholding | 106 | $18K | 9/30/2023 | View on chart |
| ZTS | ▲ Buy | Option Exercise | 308 | — | 9/30/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Goldman Sachs initiates Zoetis coverage with Neutral rating
Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.
Goldman Sachs initiates Zoetis coverage with Neutral rating. Goldman Sachs began covering Zoetis with a Neutral rating and a $74 price target. This follows recent guidance cuts that the market initially shrugged off, alongside a new board appointment. The stock currently trades near a key support level, with an RSI of 71.0 indicating strong recent momentum.